Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 1.750
+0.038 (2.22%)
Oct 7, 2025, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 571.46 million as of October 7, 2025. Its market cap has decreased by -65.35% in one year.
Market Cap
571.46M
Enterprise Value
-105.21M
Revenue
79.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.75
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 571.46M, a decrease of -89.65%. That is a compound annual growth rate of -32.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 559.05M | -43.80% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.33B |
| Nordhealth AS | 2.78B |
| Photocure ASA | 1.56B |
| ArcticZymes Technologies ASA | 1.38B |
| Thor Medical ASA | 1.32B |
| Vistin Pharma ASA | 1.02B |
| Omda AS | 1.00B |
| Gentian Diagnostics ASA | 863.65M |